Having worked Executive across multiple different stakeholder group, including academia, governments (US & International), not-for-profit Foundations, for profit organizations, including a Fortune 500 Company in Switzerland, our Founder, Dr. Shawnmarie Mayrand-Chung, PhD, JD has learned the value gained through, efficiency, collaboration & partnership space at the NIH and FDA, academia, and a Fortune 500 Company.
As one example, while working at the United States National Institutes of Health (NIH) and the Food & Drug Administration (FDA) she observed first-hand both the challenges and opportunities to finding solutions to communicable and non-communicable diseases. This process of research and discovery routinely takes several years to understand the science and develop successful treatments. Moreover, this process is never achieved without extensive financial resources, often beyond the capacity of any one single governmental, academic, non-profit, or corporate entity. To achieve success independently while sometimes possible is never without waste and inefficiency.
It was her work at the NIH and FDA, as Director for the Biomarker Consortium where she first realized the potential for greater success by bringing together resources through novel, multi-stakeholder collaborations to help advance medical research more efficiently and affordably.
The Board of Directors
(To be published shortly)